Trending...
- No Bounds Digital Acquires Draidel's HubSpot Agency Business, Expanding Reach and Capabilities
- The Well Woman Conference Comes To Philadelphia: A Powerful Experience Of Faith And Healing
- Malcolm Hill: The Laughter, Legacy and Determination Behind a Philly Comedy Mainstay
PHILADELPHIA, Nov. 9, 2023 ~ Suvoda LLC, a leading global clinical trial technology company, has successfully conducted usability testing of its electronic clinical outcomes assessment (eCOA) solution in collaboration with RWS Life Sciences. The study resulted in the certification of Suvoda eCOA as highly usable and effective for the patient population.
The findings from the RWS Life Sciences usability testing effort will be presented in a paper titled "Solidifying Usability Testing Guidelines for eCOAs from the Patient Perspective" at ISPOR Europe 2023, to be held in Copenhagen, Denmark, November 12-15. The focus group consisted of oncology patients using smartphone and tablet devices. These patients represented a variety of conditions related to their cancer diagnoses, including difficulties with gripping and reading, as well as concentration and tactile challenges. The study, which included participants ranging from ages 18 to 75, was qualitative in nature and adhered to best practices in user experience research.
More on The PennZone
Chryso Hadjidemetriou, PhD with RWS Life Sciences said "Patient-centered usability testing is valuable because it focuses on whether patients can interact with the eCOA efficiently and effectively, particularly in cases where participants may experience physical or visual accessibility challenges." He further added that "The qualitative and patient-centered process of usability testing helps to measure operational efficacy of the eCOA system; recognize design issues causing patient dissatisfaction and impeding data collection; examine software and working improvements; and understand and evaluate user interaction, with an end-goal of improving the users' experience."
Nearly all participants in the focus group found Suvoda eCOA to be easy to navigate, intuitive, clear, and well-designed. They appreciated the ease of moving through the questionnaire screens, clear instructions, and the flexibility to change answers as needed. Catherine Munera vice president of biometrics for Cara Therapeutics said "Patient-reported outcome (PRO) data is crucial in clinical studies so it's imperative to have data capture tools that are easy for patients to use and manage with minimal intervention from clinical sites." She further added that "Suvoda eCOA was incredibly easy for our patients to use; we had an increase in patient compliance in completing PRO questionnaires as compared to previous studies with other eCOA providers."
More on The PennZone
The usability testing process was conducted in accordance with current industry standards and FDA guidance to ensure the highest level of quality and compliance. Andrés Escallón vice president Suvoda eCOA practice said "Suvoda put the user experience at the center of product development so sites can focus time on patients and not on technology." He further added that "This study validates that our eCOA solution makes it easy and efficient to obtain quality patient outcomes data for submissions and approvals."
Suvoda announced general availability of its eCOA product back in May 2023 which addresses difficulties associated with traditional eCOA products by delivering simplified questionnaire licensing & localizations along with streamlined device logistics. Additionally since Suvoda's solution delivers IRT & Econsent on a single platform it helps improve data integrity & study teams benefit from improved data integrity.
The findings from the RWS Life Sciences usability testing effort will be presented in a paper titled "Solidifying Usability Testing Guidelines for eCOAs from the Patient Perspective" at ISPOR Europe 2023, to be held in Copenhagen, Denmark, November 12-15. The focus group consisted of oncology patients using smartphone and tablet devices. These patients represented a variety of conditions related to their cancer diagnoses, including difficulties with gripping and reading, as well as concentration and tactile challenges. The study, which included participants ranging from ages 18 to 75, was qualitative in nature and adhered to best practices in user experience research.
More on The PennZone
- Security Planning Tips For Your Holiday Event From Access Patrol Services
- Kellyn Co-Founder Meagan Grega Named President-Elect of the American College of Lifestyle Medicine
- Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
- Business News & Info Goes Inside Paragon FX Group's Hunt for Original Film Props
- Kitchen Table Economics: An Invitation to Think Differently
Chryso Hadjidemetriou, PhD with RWS Life Sciences said "Patient-centered usability testing is valuable because it focuses on whether patients can interact with the eCOA efficiently and effectively, particularly in cases where participants may experience physical or visual accessibility challenges." He further added that "The qualitative and patient-centered process of usability testing helps to measure operational efficacy of the eCOA system; recognize design issues causing patient dissatisfaction and impeding data collection; examine software and working improvements; and understand and evaluate user interaction, with an end-goal of improving the users' experience."
Nearly all participants in the focus group found Suvoda eCOA to be easy to navigate, intuitive, clear, and well-designed. They appreciated the ease of moving through the questionnaire screens, clear instructions, and the flexibility to change answers as needed. Catherine Munera vice president of biometrics for Cara Therapeutics said "Patient-reported outcome (PRO) data is crucial in clinical studies so it's imperative to have data capture tools that are easy for patients to use and manage with minimal intervention from clinical sites." She further added that "Suvoda eCOA was incredibly easy for our patients to use; we had an increase in patient compliance in completing PRO questionnaires as compared to previous studies with other eCOA providers."
More on The PennZone
- New Bethany, Provident Bank, Jaindl Farms and Lehigh Valley IronPigs Unite for Turkey Drive
- Grace Montessori School Awarded $56,180 to Support Scholarships for 15 Students
- Win a $5,000 VIP Family Experience at the 100th Thanksgiving Day Parade in New York City
- CB Stuffer Announces Private Sale to Secure Future of Brand Growth
- Brother Marcus Celebrates 400th Episode of The Elements of Inspiration Podcast
The usability testing process was conducted in accordance with current industry standards and FDA guidance to ensure the highest level of quality and compliance. Andrés Escallón vice president Suvoda eCOA practice said "Suvoda put the user experience at the center of product development so sites can focus time on patients and not on technology." He further added that "This study validates that our eCOA solution makes it easy and efficient to obtain quality patient outcomes data for submissions and approvals."
Suvoda announced general availability of its eCOA product back in May 2023 which addresses difficulties associated with traditional eCOA products by delivering simplified questionnaire licensing & localizations along with streamlined device logistics. Additionally since Suvoda's solution delivers IRT & Econsent on a single platform it helps improve data integrity & study teams benefit from improved data integrity.
Filed Under: Business
0 Comments
Latest on The PennZone
- Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
- Coach Bulinda Wright Advances To Top Five In National 'Top Host 2026 Competition'
- Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
- Feldman Shepherd Named as 2027 'Best Law Firm' by Best Lawyers -- Tier 1 National & Philadelphia
- The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
- Corner Property Management AAMC Awarded Community Management Contract for Belvidere at Doyle Square
- Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
- TrueDriveCost Launches Free Calculators for the Real Cost of Owning a Car
- A New Era Of Social Networking Is Here !
- Poetry Quarterly Returns in Print With Its Fall 2026 Issue, Featuring 42 Poets
- HIRO Ostomy Belt Launch by Richard O'Hamill
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
- Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
- The Well Woman Conference Comes To Philadelphia: A Powerful Experience Of Faith And Healing
- No Bounds Digital Acquires Draidel's HubSpot Agency Business, Expanding Reach and Capabilities
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
- The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms